Disc Medicine, Inc.
Company Stats
- Market Cap
- $2.5B
- as of Sep 30, 2026
- Shares Outstanding
- 38.4M
- Free Float
- 49.4%
Income Statement
- Operating Income
- -$236.0M
- Net Income
- -$212.2M
- EBITDA
- -$235.7M
Cash Flow
- Free Cash Flow
- -$181.3M
- FCF Yield
- -7.2%
- Owner FCF Yield
- -8.6%
Balance Sheet
- Cash & Equivalents
- $91.1M
Returns & Capital
- SBC, 3Y Avg
- $18.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$181.3M | — |
| FY2024 | — | -$94.4M | — |
| FY2023 | — | -$73.6M | — |
| FY2022 | — | -$42.4M | — |
| FY2021 | — | -$27.6M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 5, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges